版本:
中国

BRIEF-Cytokinetics announces start of second cohort in Phase 2 clinical trial of CK-2127107

March 29 Cytokinetics Inc

* Cytokinetics announces start of second cohort in phase 2 clinical trial of CK-2127107 in patients with spinal muscular atrophy Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐